Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2024-12-17 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | LTA · HBM Demand · Valuation Re-rating / 2026-05-27 RESEARCH
  • [Disclosure] Hanmi Semiconductor (042700) – Single Sales and Supply Contract / 2025-05-16 Semiconductors
  • [Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) Europe Marketing Authorization Application / 2026-07-24 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Decision on Paid-in Capital Increase / 2025-02-06 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Additional Listing (Third-Party Paid-in Capital Increase) / 2024-07-22 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – iM Hi Investment | Demand Visibility · 2H24 Rebound Catalysts · AI & Automotive Mix / 2024-02-13 RESEARCH
  • [Disclosure] Hanwha Ocean (042660) – Suspension of Production / 2025-09-04 Disclosures

[Disclosure] ISU PETASYS(007660) – Results of Annual General Meeting of Shareholders / 2025-03-31

Posted on March 31, 2025August 1, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ISU PETASYS approved its FY2024 financial statements (consolidated revenue of KRW 836.9B, operating profit of KRW 101.9B), a cash dividend of KRW 150 per common share, and the re-appointment of an independent director at its AGM.

📊 [Key Disclosure Details & Financial Figures]

  • Disclosure Type: Results of Annual General Meeting of Shareholders
  • Company Name: ISU PETASYS (Stock Code: 007660)
  • AGM Date: March 31, 2025

1. FY2024 Financial Statements Reporting and Approval

  • Consolidated Financial Figures:
    • Revenue: KRW 836.9B (836,867 million KRW)
    • Operating Profit: KRW 101.9B (101,879 million KRW)
    • Net Income: KRW 74.0B (74,034 million KRW)
    • Total Assets: KRW 790.1B (790,136 million KRW)
    • Total Liabilities: KRW 462.6B (462,609 million KRW)
    • Total Equity: KRW 327.5B (327,527 million KRW)
    • Earnings Per Share (EPS): KRW 1,171
  • Separate Financial Figures:
    • Revenue: KRW 718.7B (718,729 million KRW)
    • Operating Profit: KRW 78.5B (78,480 million KRW)
    • Net Income: KRW 65.2B (65,248 million KRW)
    • Total Assets: KRW 687.2B (687,152 million KRW)
    • Total Liabilities: KRW 356.9B (356,900 million KRW)
    • Total Equity: KRW 330.3B (330,252 million KRW)
    • Earnings Per Share (EPS): KRW 1,032
  • Auditor’s Opinion: Unqualified (both consolidated and separate)

2. Cash Dividend Details

  • Dividend Type: Year-end Cash Dividend
  • Dividend Per Common Share: KRW 150
  • Total Dividend Amount: KRW 9.49B (9,486,962,850 KRW)
  • Dividend Yield: 0.4% for common stock

3. Executive Appointments & Board Composition

  • Independent Director Appointment: Re-appointment of Yang Seung-han (3-year term, Professor at Kyungpook National University)
  • Board & Auditor Composition Post-AGM:
    • Total Directors: 4 (1 Independent Director, 25% ratio)
    • Full-time Auditor: 1

4. Status of Proposed Agendas

  • Agenda Item 1: Approval of FY2024 Financial Statements (changed to reporting item)
  • Agenda Item 2: Appointment of Independent Director → Passed
  • Agenda Item 3: Amendment of Executive Retirement Allowance Regulations → Passed
  • Agenda Item 4: Approval of Remuneration Limit for Directors → Passed
  • Agenda Item 5: Approval of Remuneration Limit for Auditor → Passed

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Dividend Payment Settlement and Post-AGM Filings

This filing documents the formal approval of FY2024 financial statements and a cash dividend of KRW 150 per common share by shareholders at the AGM. Confirming that the dividend payment is fully distributed within the statutory timeframe and verifying final financial entries is important for evaluating the completion of corporate governance and profit distribution procedures. Final settlement details can be reviewed in the official FY2024 Annual Report and the Statement of Appropriation of Retained Earnings submitted to DART.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official submission data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] PSK Holdings (031980) – Results of Annual General Meeting of Shareholders / 2025-03-31
Next Post: [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2025-04-01

Related Posts

  • [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-03-25 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Occurrence of Serious Industrial Accident / 2026-03-16 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Acquisition of Shares or Equity Securities of Other Corporations / 2024-11-26 Disclosures
  • [Disclosure] Hyundai Motor(005380) – Investor Relations(IR) Schedule / 2026-07-16 Disclosures
  • [Disclosure] Celltrion (068270) – Execution of Joint R&D and License Agreement for PD-1 x VEGF x IL-2v Tri-functional Fusion Protein / 2025-10-31 Disclosures
  • [Disclosure] PSK Holdings (031980) – Value-up Plan (Voluntary Filing) / 2026-03-30 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the US / 2026-03-12 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | MLCC Fab Utilization Surge · Operational Leverage · AI Growth / 2024-08-01 RESEARCH
  • [Disclosure] Hana Micron (067310) – Results of Annual General Meeting of Shareholders / 2024-03-28 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Status of Compliance Program Operation / 2026-07-23 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Closure of Shareholder Register or Designation of Record Date / 2025-12-16 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding / 2026-05-20 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Hana Securities | Shareholder Return & Value Enhancement Plan · Prioritizing Financial Health / 2024-11-28 RESEARCH
  • [Disclosure] Samsung Biologics (207940) – Trading Suspension and Lifting of Suspension (Material Disclosure) / 2025-05-22 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme